Procyrion, Inc. announces the appointment of Andrew Davis as Chief Commercial Officer, effective immediately. He will lead the company's therapy development initiatives focusing on the enrollment of the DRAIN-HF pivotal trial.
Who to call at Procyrion, and when
A new leader at Procyrion brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Procyrion raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Procyrion, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Procyrion. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Procyrion
Location
3900 ESSEX LANE
Houston, Texas, United States
About
Procyrion™, Inc. is a privately held medical device company dedicated to providing effective treatment options for patients with cardiac and renal impairment. The company is developing the Aortix™ percutaneous mechanical circulatory support device, a catheter-deployed pump technology that uniquely harnesses fluid entrainment to pump blood to address multiple conditions with significant unmet needs. Aortix is limited by Federal law to investigational use only and is not approved for sale in any geography.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Procyrion changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HoustonManufacturingBiotechnologyHealthcareHealth CareMedicalMedical Device